Moderna (MRNA) PT Raised to $150 at BofA Securities
Tweet
Share
E-mailGet Alerts MRNA Hot Sheet
Price: $108.85 +0.89%
Rating Summary:
11 Buy, 13 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Rating Summary:
11 Buy, 13 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Join SI Premium – FREE
BofA Securities analyst Geoff Meacham raised the price target on Moderna (NASDAQ: MRNA) to $150.00 (from $140.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Morgan Stanley Comments on Moderna (MRNA) Collaboration with OpenAI
- Compass Minerals International (CMP) PT Lowered to $15 at Deutsche Bank
- Equifax (EFX) PT Lowered to $263 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
